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Longitudinal intestinal lengthening and tapering
Background: In remains unclear why in some short bowel syndrome (SBS) patients, the remaining small bowel
(SB) dilates excessively leading to requirement of tapering surgery.
Methods: Among SBS children, we retrospectively analyzed risk factors for tapering surgery with logistic regres-
sion and compared the outcome of operated patients (n= 16) to those managed conservatively (n= 44) with
Cox proportional hazards regression.
Results: SBS was caused by necrotizing enterocolitis (NEC) (n=31), SB atresia (SBA) (n=13), midgut volvulus
(n= 12), or gastroschisis (n=4). Patients with spontaneous symptomatic SB dilatation unable to wean paren-
teral nutrition (PN) underwent tapering surgery at median age of 1.04 (interquartile range 0.70–3.27) years.
Missing ICV was related to an 8-fold (p = 0.003) increased risk while SBA diagnosis was related to a 13-fold
risk of tapering surgery (p b 0.001). Increasing SB length and NEC diagnosis were protective of tapering (p =
0.027–0.004). Of operated patients, 75% reached enteral autonomy during follow-up and their postoperative ad-
justed PN weaning rate was similar to nonoperated children (p = 0.842).
Conclusion: SBS children with short remaining SB, missing ICV, and SBA etiology are more likely while NEC pa-
tients are less likely than others to necessitate tapering surgery. Postoperative PN weaning rates were compara-
ble to patients who initially had more favorable intestinal anatomy and adapted without surgery.
© 2017 Elsevier Inc. All rights reserved.Intestinal failure (IF) in children is defined as reduction of functional
intestinal mass below the minimum needed for sufficient absorption of
fluid and nutrients, and requirement of long-term parenteral nutrition
(PN) to sustain survival and maintain adequate growth instead [1,2].
The most common reason for IF among children is short bowel syn-
drome (SBS) caused by extensive small bowel (SB) resection, indicated
during infancy for conditions such as necrotizing enterocolitis (NEC),
midgut volvulus (MGV), SB atresia (SBA), and gastroschisis [3,4]. In-
creasing remaining bowel length, preserved ileocecal valve (ICV), and
reestablishment of intestinal continuity improve the chances for
weaning off PN, which is the main goal in the treatment of SBS patients
[2,3,5,6].
After resection, the remaining SB undergoes structural and function-
al changes to improve its absorptive capacity [7,8]. In some patients, the
remaining SB dilates as part of the physiological adaptation processcterial overgrowth; HR, hazard
uartile range; LILT, longitudinal
s; NEC, necrotizing enterocoli-
el; SBA, SB atresia; STEP, serial
ki University Hospital, P.O. Box
; fax: +358 9 47175737.
en).[3,7,8]. Although this increases the bowel absorptive surface, excessive
SB dilatation may also impair intestinal motility and promote bacterial
overgrowth (BO), which in turn predispose SBS patients to septic infec-
tions, D-lactate acidosis, and malabsorption [9,10]. We have recently
demonstrated that adaptive SB dilatation is an independent risk factor
for prolonged PN duration and decreased survival in SBS children [11].
In addition to PN dependence, anatomy of the remaining bowel and
the etiology of SBS possibly influence the risk of excessive adaptive dila-
tation [10–13].
Tapering surgery of dilated SB in order to relieve the related func-
tional problems has become increasingly popular during recent years
especially in pediatric patients [14–20]. In serial transverse enteroplasty
(STEP) and longitudinal intestinal lengthening and tapering (LILT), SB
length is increased by narrowing the dilated intestine while preserving
all absorptive mucosal surface [19,21]. Alternatively, dilated parts may
be narrowed by simple tapering enteroplasty or segmental resection
when the remaining bowel is not critically short [22]. SBS patients un-
able to wean from PN because of complications related to SB dilatation
are considered as candidates for tapering surgery [15,17,19]. Among
such patients, tapering increases the likelihood of weaning off PN possi-
bly by reducing BO, by improving bowel motility, and by promoting ab-
sorption [14–20,23]. Tapering may also ameliorate liver dysfunction by
decreasing the need for PN [24]. However, few studies have compared
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edwithout surgery [25], and it remains unclear how SBS children neces-
sitating tapering differ from patients who adapt without surgical
procedures.
Identification of risk factors for the need of tapering surgery would
help to recognize the most susceptible SBS patients earlier and target
particular attention at them. Moreover, as tapering surgery has become
an established practice in the treatment of SBS, its efficacy should be
evaluated not only by comparing thepreoperative and postoperative re-
sults but also by paralleling the outcome of operated patients to those
managed conservatively. To this end, we aimed to analyze risk factors
for the need of tapering surgery for spontaneous adaptation-related ex-
cessive small intestinal dilatation, as well as to study the respective PN




This was a retrospective study including all patients with IF caused
by SBS treated by our intestinal rehabilitation program [26] in
2002–2015 (n = 61). Inclusion criteria were SB resection N50% of age-
adjusted reference value, or duration of PN for over two consecutive
months [4,27,28]. Patients with tapering surgery following controlled
bowel expansion (n=1) and other etiology of IF (n=33), such as pri-
mary motility disorders, mucosal diseases, and lymphatic disorders
were excluded. Medical records were reviewed for SBS etiology, gesta-
tional age andweight, duration of PN, plasma citrulline levels, intestinal
anatomy, and SB width in contrast series. Bowel length was expressed
both as absolute values and as percentage of age-adjusted reference
values [28] while the presence of ICV and ileumwas recorded as absent
or present. Maximal width of SB perpendicular to the longitudinal axis
of the bowelwasmeasured in contrast SB series as described previously
[11]. SBwidthwas expressed both asmm(absolute SBwidth) and as in-
ternally standardized ratio to the height of the fifth lumbar vertebra (SB
diameter ratio) [11]. At last follow-up, plasma alanine aminotransferase
(ALT) and bilirubin levels aswell as liver biopsy findings were recorded,
and growth was assessed by using height z-scores as well as age-
adjusted ISO-BMI for children aged 2–18 years; age-adjusted weight-
to-height percentiles (based on national data) for children under
2 years of age; and the BMI for patients older than 18 years [26].
1.2. Tapering surgery
Tapering surgery was considered in SBS patients with excessive
bowel dilatation who were unable to wean from parenteral support
and presented with complications related to symptoms of SB dilatation,
such as BO or dysmotility. The presence of one or several dilated SB seg-
ments clearly exceeding the diameter of normal-caliber SB in the same
contrast SB series was a prerequisite for tapering surgery. BO and
dysmotility were diagnosed based on clinical symptoms, including ab-
dominal bloating, vomiting, increased intestinal secretions, and inability
to advance enteral nutrition. Altogether 16 patients underwent tapering
procedures, including STEP, LILT, tapering enteroplasty, and resection of
dilated bowel segment. In this study, resection of dilated segment was
included in tapering procedures because it was used as STEP, LILT, or ta-
pering enteroplasty to treat excessively dilated SB, however, for patients
with limited dilatation and sufficient remaining small intestinal length.
Previously standardized surgical techniques for STEP and LILT were
followed [17,19]. Simple tapering of a dilated bowel segment was per-
formed with a linear stapler along the long axis of a dilated bowel seg-
ment [22]. Indications for tapering surgery and possible postoperative
complications were recorded. Primary and retapering procedures
were analyzed separately. One of the primary tapering procedures
(STEP) had been performed in another hospital, after which the patientwas referred to us and later underwent a reoperation for symptomatic
redilatation.
1.3. Statistical methods
Data are presented as medians with interquartile ranges (IQR) or as
frequencies. Spearman rank correlation was used to examine associa-
tions between variables. Mann–Whitney U test was used to compare
continuous variables, Wilcoxon signed-rank test to compare repeated
measurementswithin groups, and Fisher exact test to compare frequen-
cies between subgroups. We conducted simple andmultiple logistic re-
gression analyses to further estimate the magnitude of association
between different variables and the need for tapering surgery. The
odds ratios (ORs) with 95% confidence intervals (CIs) were computed,
and statistically significant predictors from the simple regression
model were chosen for themultiple regression analysis. As SB dilatation
was a prerequisite for tapering surgery, SB width or SB diameter ratio
were not included in these analyses. Kaplan–Meier plots with the log-
rank test were used to compare the PN weaning rates of operated pa-
tients to nonoperated patients, and those receiving PN at the end of
follow-up or who diedwhile receiving PNwere censored from the anal-
ysis. Finally, we studied the predictive values for different variables on
cumulative rates of weaning off PN and survival by generating hazard
ratios (HRs) with 95% CIs with Cox proportional hazards regression
model. Variables showing statistically significant univariate associations
with PN weaning rates were included in the multivariate model. The
level of significance was set at p b 0.05 and all analyses were carried
out with SPSS version 22.
1.4. Ethics
The study protocol was approved by the hospital ethical committee.
2. Results
2.1. Patient characteristics
We identified 60 eligible patients with IF caused by SBS (males 58%,
n = 35). At the time of study, intestinal continuity had been
reestablished in all and none had an enterostomy. Baseline diagnoses
were necrotizing enterocolitis (NEC) (n = 31), midgut volvulus
(MGV) (n= 12), small bowel atresia (SBA) (n=13), and gastroschisis
(n = 4) (Table 1). Four patients with both SBA and gastroschisis were
analyzed in the SBA group. Median residual small bowel length was
40 (25–60) cm while colon length was 32 (24–41) cm, corresponding
to 25% (17%–44%) and 93% (61%–100%) of age-adjusted reference
values, respectively [28]. The ICV was missing in 28 (47%) and no
ileum was remaining in 27 (45%). Median gestational age was 34
(28–36) weeks and birth weight was 2090 (960–3035) grams. Median
plasma citrulline was 13 (10–17) before and 24 (20–29) after weaning
off PN (p b 0.001).
2.2. Tapering surgery
Altogether 16 patients (27%) had undergone tapering procedures. In
addition to bowel dysmotility, inability to increase enteral intake and
BO were the most common indications for tapering surgery (Table 2).
The patient having undergone bowel resection had been previously off
PN before developing symptomatic segmental SB dilatation and becom-
ing PN dependent again. Postoperative complications requiring
relaparotomy occurred in two while milder complications in two pa-
tients (Table 2). Preoperative contrast SB series were performed on 10
patients while postoperative contrast SB series on 13 patients. Themax-
imal SB diameter ratio in these contrast series decreased significantly
following tapering (Table 2, p = 0.009), while no decrease in maximal
absolute SB width was observed.
Table 1
Characteristics of patients managed with (n = 16) or without (n = 44) tapering surgery.
Tapering (n = 16) No tapering (n = 44) p-Value
Baseline diagnosis
NEC, n (%) 3 (19%) 28 (64%) 0.003
SBA, n (%) 9 (56%) 4 (9%) b0.001
MGV, n (%) 3 (19%) 9 (20%) 1.000
Gastroschisis, n (%) 1 (6%) 3 (7%) 1.000
Remaining SB length (cm) 30 (23–41) 50 (30–61) 0.019
Remaining SB length (%) 24 (18–26) 26 (17–49) 0.270
Remaining colon length (cm) 28 (21–31) 39 (24–55) 0.026
Remaining colon length (%) 75 (59–90) 100 (66–100) 0.061
ICV missing, n (%) 13 (81%) 15 (34%) 0.003
Maximal SB width (mm) 41 (36–60) 25 (20–30) b0.001
Maximal SB diameter ratio 3.54 (2.20–4.00) 2.74 (2.08–3.17) 0.064
Total duration of PN (months) 19.5 (10.0–47.6) 6.72 (3.05–12.5) b0.001
Birth weight (grams) 2400 (1610–3510) 1250 (740–2400) 0.030
Gestational age (weeks) 35 (31–36) 30 (25–35) 0.140
Weaned off PN, n (%) 12 (75%) 38 (86%) 0.433
Survival, n (%) 15 (94%) 40 (91%) 1.000
Follow-up plasma ALT 31 (21–46) 27 (19–46) 0.543
Follow-up plasma bilirubin 6 (3–8) 6 (3–11) 0.467
Follow-up ISO-BMI (n = 42) 20.6 (17.8–24.2) 19.8 (18.3–21.8) 0.990
Follow-up BMI (n = 6) 17.5 (17.2–17.7) 16.9 (16.4–19.0) 0.700
Follow-up weight-for-height (%) (n = 12) −7.0 (−7.5 to −2.0) −7.0 (−7.0 to −4.0) 1.000
Follow-up height z-score (n = 54) −0.95 (−2.4 to 0.00) −1.2 (−1.8 to −0.70) 0.743
ALT = alanine aminotransferase, ICV = ileocecal valve, MGV = midgut volvulus, NEC = necrotizing enterocolitis, PN = parenteral nutrition, SB = small bowel, SBA = small bowel
atresia. Maximal SB width and maximal SB diameter ratio during follow-up recorded for each patient. ISO-BMI reported for patients aged 2–18 years, BMI for patients aged >18 years,
and weight-for-height percentiles for patients aged b2 years at last follow-up. Height z-scores reported for all patients younger than 18 years.
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Patients who underwent tapering had higher maximal SB width,
shorter remaining SB and colon, higher birth weight, and ICV missing
more frequently when compared to patients not undergoing surgery
(Table 1). SBA patients were more likely while NEC patients less likely
to undergo tapering than patients withMGV or gastroschisis. According
to univariate regression, missing ICV, decreasing remaining SB length,Table 2
Operative characteristics of patients undergoing tapering surgery (n = 16).
Tapering procedure, total n 16
STEP, n (%)⁎ 10 (63%)
LILT, n (%) 2 (13%)
Tapering enteroplasty, n (%) 3 (19%)
Resection, n (%) 1 (6%)
Indications for surgery⁎⁎, total n 15
Dysmotility, n (%) 15 (100%)
Bacterial overgrowth, n (%) 10 (67%)
Inability to increase enteral intake, n (%) 12 (80%)
Vomiting, n (%) 8 (53%)
D-lactate acidosis, n (%) 2 (13%)
Obstructive symptoms, n (%) 2 (13%)
Age at tapering (years)⁎⁎ 1.04 (0.70–3.27)
Postoperative complications⁎⁎, total n 4 (27%)
Wound infection, n (%) 1 (7%)
Intraabdominal hematoma, n (%) 1 (7%)
Wound dehiscence, n (%) 1 (7%)
Bowel perforation, n (%) 1 (7%)
Retapering, n (%) 6 (38%)
Weaned off PN, n (%) 12 (75%)
Time to wean off PN after tapering (months) 5.6 (0.30–20.3)
Preoperative NG/gastrostomy tube feeding 6 (38%)
Postoperative NG/gastrostomy tube feeding 10 (63%)
Preoperative maximal SB diameter ratio 3.55 (2.19–3.83)
Postoperative maximal SB diameter ratio 2.32 (1.92–2.87)
Preoperative maximal SB width (mm) 36 (33–40)
Postoperative maximal SB width (mm) 35 (29–60)
Preoperativemaximal small bowel (SB)width and SB diameter ratiomeasurements avail-
able for 10 patients, postoperative measurements available for 13 patients.
LILT = longitudinal intestinal lengthening and tapering, NG = nasogastric,
PN = parenteral nutrition, STEP = serial transverse enteroplasty.
⁎ Including one STEP procedure performed in another hospital.
⁎⁎ Data missing for the patient who underwent primary surgery in another hospital.and SBA etiology compared to MGV and gastroschisis were significant
predictors of surgery (Table 3). In the multiple regression analysis ad-
justed for these statistically significant variables, remaining SB length
(OR 0.96, 95% CI 0.92–1.00, p = 0.050) and NEC etiology compared to
gastroschisis andMGV (OR 0.02, 95% CI 0.00–0.45, p=0.021) remained
statistically significant predictors of tapering surgery. When all other
patients were compared to NEC, their univariate OR for tapering was
7.58 (95% CI 1.88–30.7, p = 0.004), suggesting that NEC etiology was
protective of tapering surgery. Comparing SBA patients to others, their
OR for surgery was 12.9 (95% CI 3.09–53.5, p b 0.001).
2.4. Retapering surgery
Retapering was performed in six patients (NEC, n = 3; SBA, n = 2;
MGV, n = 1) at the age of 2.78 (1.73–14.8) years, 1.34 (0.96–17.0)
years after initial tapering. Reoperations included four STEP procedures,
one bowel resection, and one tapering enteroplasty. In addition to
dysmotility (n = 6), BO (n = 4), inability to increase enteral intake
(n = 4), obstructive symptoms (n = 2), and weight loss (n = 1) were
among indications for retapering. In addition, one patient underwentTable 3
Associations between the need for tapering surgery and baseline patient characteristics
assessed with simple logistic regression.
OR (95% CI) p-Value
Etiology
Gastroschisis/MGV 1.00 (Ref)
NEC 0.32 (0.06–1.66) 0.176
SBA 6.75 (1.32–34.57) 0.022
Remaining SB length (cm) 0.97 (0.94–1.00) 0.027
Remaining SB length (%) 0.97 (0.94–1.01) 0.797
Remaining colon length (%) 0.99 (0.96–1.01) 0.231
ICV missing 8.38 (2.06–34.03) 0.003
PN duration 1.01 (0.98–1.04) 0.562
Birth weight 1.00 (–) 0.100
Gestational age 1.21 (0.96–1.52) 0.110
Duration of parenteral nutrition (PN) at tapering analyzed for operated patients and total
PN duration for others.
95% CI = 95% confidence interval, ICV = ileocecal valve, MGV = midgut volvulus,
NEC = necrotizing enterocolitis, OR = odds ratio, SBA = small bowel atresia.
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after retapering were recorded. Patients' median SB length was 42
(25–28) cm, corresponding to 24% (22%–29%) of age-adjusted bowel
length, and none had ICV remaining; however, no statistically signifi-
cant differences in patient characteristics, PN duration, or bowel anato-
mywere observed between patients undergoing retapering vs. only one
tapering procedure. Maximal absolute SB width was 50 (25–88) mm
prior to retapering and 28 (25–34) mm postoperatively, and maximal
SB diameter ratio was 2.26 (1.92–4.00) preoperatively, decreasing to
2.04 (1.93–2.45). No statistically significant decrease in either measure,
however, was observed.
2.5. Predictors of weaning off parenteral nutrition
Of patients undergoing tapering, 88% (n = 14) were continuously
PN dependent at time of surgery while 25% (n = 4) required any kind
of parenteral support at the end of the follow-up (p=0.001). Although
two patients were not on continuous PN at time of tapering, they had
experienced repeated episodes of dehydration necessitating parenteral
rehydration. Preoperative duration of PN was 10.5 (7.65–14.3) months,
postoperative PN duration was 8.17 (1.09–28.2) months, and total PN
duration was longer in operated patients when compared to others
(Table 1). Of patients treated without surgery, 14% (n = 6) were still
PN dependent or had died while on PN by the end of the follow-up
(p=0.433 when compared to operated patients). Although the overall
cumulative probability of weaning off PN was higher in patients who
were managed without tapering surgery (Table 4, Figs. 1A and 2A),
the cumulative PN weaning rates analyzed after tapering surgery were
comparable between subgroups (Figs. 1B and 2B).
2.6. Survival, liver function, and growth
Survival was comparable between operated patients and those
treated without surgery (Table 1), and none of the patients in either
group had been listed for intestinal transplantation by the end of the
follow-up. No significant predictors of survival were identified; the
HRs for the length or percentage of remaining SB or colon, the presence
of ICV, maximal SB width or maximal SB ratio, gestational age, birth
weight, tapering surgery, and etiology of SBS were nonsignificant. At
last follow-up at amedian age of 4.99 (2.83–10.23) years, plasma biliru-
bin and ALT, height z-scores, and weight parameters in children (ISO-
BMI for those aged 2–18 years; weight-for-height percentiles for those
younger than 2 years) were in normal range, while BMI of patients
older than 18 years (n = 6) was slightly below normal (Table 1).
Follow-up liver biopsies (total n = 39; operated patients n = 14)
showed cholestasis in 9 (23%), steatosis in 9 (23%), and any fibrosis in
24 (62%) patients, of which Metavir stage 1 was observed in 12 (31%),
stage 2 in 11 (28%), and stage 3 in one patient (5%). The presence ofTable 4
Hazard ratios (HR) with 95% confidence intervals (CI) for weaning off parenteral nutrition.
Univariate
HR (95% CI)
Other etiology vs. SBA 1.91 (0.89–4.09)
NEC vs. other etiology 0.64 (0.36–1.13)
No tapering vs. tapering surgery 2.75 (1.36–5.57)
Remaining SB length (%) 1.03 (1.02–1.05)
Remaining SB length (cm) 1.03 (1.02–1.04)
Remaining colon length (%) 1.01 (0.99–1.02
ICV preserved 1.79 (1.01–3.17)
Maximal SB diameter ratio 0.75 (0.52–1.08)
Maximal SB width 0.63 (0.46–0.86)
Gestational age 0.94 (0.86–1.03)
Birth weight 1.00 (−)
Results obtained fromCox proportional hazards regressionmodel. Tapering surgery, percentage
multivariate model. Maximal SB width was omitted from the multivariate analysis because of
NEC = necrotizing enterocolitis, SBA = small bowel atresia.histological cholestasis or the severity of fibrosis did not differ between
patient subgroups, whereas steatosis wasmore frequent among operat-
ed patients than others (8 vs. 1, p b 0.001).
3. Discussion
This study demonstrates that in SBS children, short remaining SB,
missing ICV, and baseline diagnosis of SBA are associated with an in-
creased need for tapering surgery, while NEC patients are more likely
than others to adapt without surgery. Total duration of PN was longer
in children who underwent tapering surgery, however, by the end of
the follow-up, PNweaning and survival rates were similar among oper-
ated and nonoperated patients. After tapering surgery, 75% of children
were able to reach enteral autonomy, and the cumulative PN weaning
rates were comparable to patients treated without adaptive surgery
who had a significantly longer intestinal remnant and more frequently
preserved ICV.
The benefits of tapering surgery in PN dependent SBS patients are
well-documented [14–20,24]. In most cohorts, median SB length of op-
erated patients has been b50 cm, most have had no ICV remaining, and
gastroschisis and SBA have been reported as predominant diagnoses
over NEC and MGV [14,15,18,20,25]. PN dependence is an established
risk factor for BO and SB dilatation [9,10,12,13,29], in addition, we
have recently demonstrated that SBS children with short remaining SB
and missing ICV have wider SB than others, and SBA compared to
other etiologies relates to an increased SB diameter ratio [11]. However,
whether specific risk factors or certain patient characteristics relate to
the need for tapering surgery among SBS patients has not been studied
earlier. Despite some limitations, including the retrospective study de-
sign and relatively small patient sample, this is the first study systemat-
ically analyzing the predictors of tapering surgery and comparing the
outcomes of SBS patients treated either with or without tapering. In ad-
dition to other tapering procedures,we included two resections of dilat-
ed SB segment in this study, since among childrenwith sufficient bowel
length, the end-result and objective of resection essentially correspond
to those of STEP, LILT, and simple tapering.
Our results suggest that SBA patients are 13-fold more likely while
NEC patients 8-fold less likely than others to require tapering. In SBA,
smooth muscle hypertrophy as well as hypoplasia of intramural nerves
and Cajal cells in the proximal, dilated bowel predispose to dysmotility
[30–32]. The SB proximal to atresia dilates slowly during fetal develop-
ment [31,32] whereas in NEC, an ischemic injury develops during days
in a previously intact bowel wall in usually markedly premature infants
with a great potential to age-related bowel growth [28,33]. These dis-
tinct etiologies may explain the observed differences in the need for ta-
pering surgery between SBS subgroups. Dysmotility is common also in
gastroschisis, where the exposure of intestines to amniotic fluid, forma-
tion of inflammatory peel, and intramural histopathology includingMultivariate
p-value HR (95% CI) p-value
0.096
0.123
0.005 2.35 (1.11–5.00) 0.026
b0.001 1.03 (1.02–1.05) b0.001
b0.001
0.424





of remaining small bowel (SB), and thepresence of ileocecal valve (ICV) are included in the
its high correlation with tapering surgery (r = 0.642). Total n = 60.
Fig. 1. Cumulative parenteral nutrition (PN) weaning rates for SBS patients having (n=16) and not having (n=44) undergone tapering surgery by taking into account total duration of
PN (A) and PN duration after tapering for operated patients (B). Survival analyzed with the Kaplan–Meier method and subgroups compared by using the log-rank test.
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considered responsible for abnormal motility [33–38]. Possibly because
of small number of childrenwith isolated gastroschisis, they showed no
increased risk for tapering in the present study. However, as
gastroschisis patients are overrepresented in other tapering reports
[14,18,20,25], active screening for SB dilatation in PN dependent pa-
tients with SBA, gastroschisis, or both seems justified.
Short length of remaining SB andmissing ICV are known to relate to
prolonged PN duration and poor prognosis among SBS patients
[3,5,19,39–41]. This study demonstrates these anatomical factors are
also independent risk factors for tapering surgery. It appears rational
that patients with the shortest SB have the greatest tendency for
bowel dilatation to increase its absorptive surface. The mechanism
through which resection of the ileocecal region could promote dilata-
tion and dysmotility is not as straightforward. Instead of the ICV acting
as a physiological barrier prohibiting bacterial translocation from theFig. 2.Adjusted probabilities for remaining on parenteral nutrition (PN) for SBS patients having
duration of PN (A) and PN duration after tapering for operated patients (B). Results obtained fcolon, the distal ileum has been suggested to be more important in
preventing SBS patients from the development of dysmotility, BO, and
pathological dilatation [10,12,13,42]. Resection of the ileocecal region
not only predisposes to bile acid malabsorption and altered intestinal
microbiota, butmay alsoweaken the propulsive peristalsis and interfere
with regulation of adaptive bowel growth by impairing secretion of gut
hormones which expression is confined to the distal ileum and the
proximal colon, such as glucagon-like-peptides 1 and 2 and peptide
YY [8–10,43]. As the remaining SB is not capable of fully compensating
for these specific functions [8], removal of the ileum and proximal
colon may be the reason for the increased need for tapering in patients
with missing ICV. In the multiple regression analysis, we found missing
ICV as themost significant risk factor for tapering.Moreover, noneof the
patients undergoing retapering had ICV remaining, further supporting
the theory that its absence predisposes SBS children to complications
related to SB dilatation.(n=16) and not having (n=44) undergone tapering surgery by taking into account total
rom the Cox proportional hazards regression analysis.
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found to be prognostic of prolonged PN duration. In addition, patients
having undergone tapering and those with wide SB in contrast series
were less likely to wean off PN than others. In a previous study based
on the same population, we have demonstrated that SB dilatation is a
major risk factor for prolonged PN and decreased survival [11]. Here,
the observed weaker association between SB dilatation and PN depen-
dence is attributable to the main outcome being PN status at the end
of the follow-up, when tapering surgery had partly overcome the nega-
tive predictive effect of dilatation. The finding that patients who
underwent tapering had overall lower cumulative PN weaning rates
than those treated conservatively likely reflects their less favorable in-
testinal anatomy, as SB length, width, and missing ICV were all predic-
tive of both tapering surgery and weaning off PN. Importantly, after
tapering, cumulative PN weaning rates were similar between sub-
groups, and the observed reduction in the proportion PN dependent pa-
tients postoperatively compares favorably with other reports
[14,16,18,20]. Our results demonstrate that not only was surgery bene-
ficial but it improved the outcome of operated patients to a level compa-
rable to children who initially had longer SB, longer colon, and ICV
preserved more frequently.
Our findings support the concept that tapering surgery should be
considered in SBS children with excessively dilated SB when PN
weaning process stagnates despite optimal medical and nutritional
management [15,17,19]. Although postoperative complications are rel-
atively uncommon, their possibility should be taken into account in the
risk–benefit analysis of an individual patient. Considering all tapering
and retapering procedures performed on our patients, the rate of post-
operative complications was 17%, which is comparable to other pub-
lished reports [15,18,44]. After tapering, SB diameter ratio but not
absolute SB width decreased significantly, possibly because of increas-
ing age of patients between the measurements. As absolute SB width
depends on patient age and size, SB diameter standardized to vertebral
height is possibly a more reliable way to assess SB dilatation in children
[11]. Unfortunately, a significant proportion of SBS patients develop
redilatation and some also require retapering surgery [14,15,18,29].
While we were not able to identify any risk factors for retapering, the
short length of remaining SB and absence of ICV in all patients undergo-
ing retapering suggest that these anatomical characteristics continue to
promote SB dilatation. Little evidence is available on the pathogenesis of
redilatation [9,10,29]. Although postponing tapering surgery beyond
the most efficient period of intestinal adaptation, first year after resec-
tion, might decrease the magnitude of redilatation, it may not be possi-
ble in all SBS children [15,19].
We have demonstrated that SBS childrenwith resected ICV, short re-
maining SB, and SBA diagnosis are likely to require tapering surgery to
facilitate weaning off PN, while NEC patients more probably than others
adapt without surgery. In addition to carefully monitoring SBS children
with poor prognostic characteristics; short remaining SB and missing
ICV, attention should be drawn to SBS etiology which influences the
need for tapering surgery. The probability of weaning off PN after taper-
ing was comparable to children who required no adaptive surgery,
demonstrating that in carefully selected patients, tapering surgery pro-
motes enteral autonomy efficiently.
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